Brad R. Rosenberg

5.1k total citations · 2 hit papers
36 papers, 2.5k citations indexed

About

Brad R. Rosenberg is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Brad R. Rosenberg has authored 36 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Immunology and 9 papers in Epidemiology. Recurrent topics in Brad R. Rosenberg's work include interferon and immune responses (8 papers), RNA regulation and disease (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Brad R. Rosenberg is often cited by papers focused on interferon and immune responses (8 papers), RNA regulation and disease (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Brad R. Rosenberg collaborates with scholars based in United States, Denmark and France. Brad R. Rosenberg's co-authors include Jorg J. A. Calis, F. Nina Papavasiliou, Charles M. Rice, Tony Sun, Xianfang Wu, Yingpu Yu, Claire Hamilton, Hans-Heinrich Hoffmann, Stephanie L. Sarbanes and Viet Loan Dao Thi and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Brad R. Rosenberg

34 papers receiving 2.4k citations

Hit Papers

Human ADAR1 Prevents Endogenous RNA from Triggering Trans... 2017 2026 2020 2023 2018 2017 100 200 300

Peers

Brad R. Rosenberg
Linda Smit Netherlands
Chen Zhao China
Rebecca S. LaRue United States
Mark Renz United States
Brad R. Rosenberg
Citations per year, relative to Brad R. Rosenberg Brad R. Rosenberg (= 1×) peers Nabila Jabrane‐Ferrat

Countries citing papers authored by Brad R. Rosenberg

Since Specialization
Citations

This map shows the geographic impact of Brad R. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad R. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad R. Rosenberg more than expected).

Fields of papers citing papers by Brad R. Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad R. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad R. Rosenberg. The network helps show where Brad R. Rosenberg may publish in the future.

Co-authorship network of co-authors of Brad R. Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Brad R. Rosenberg. A scholar is included among the top collaborators of Brad R. Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad R. Rosenberg. Brad R. Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Humblin, Étienne, Nataliya Prokhnevska, Abishek Vaidya, et al.. (2025). The costimulatory molecule ICOS limits memory-like properties and function of exhausted PD-1+CD8+ T cells. Immunity. 58(8). 1966–1983.e10. 4 indexed citations
2.
Acklin, Joshua A., Shu Horiuchi, Satoshi Ikegame, et al.. (2024). Immunological landscape of human lymphoid explants during measles virus infection. JCI Insight. 9(17). 1 indexed citations
3.
Lercher, Alexander, Jin‐Gyu Cheong, Michael J. Bale, et al.. (2024). Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease. Immunity. 57(11). 2530–2546.e13. 17 indexed citations
4.
Cohen, Phillip, Oded Danziger, Roosheel S. Patel, et al.. (2023). Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single-cell RNA sequencing. Microbiology Spectrum. 11(5). e0077623–e0077623. 4 indexed citations
5.
Nilsson-Payant, Benjamin E., Boris Bonaventure, Chengjin Ye, et al.. (2023). SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication. mBio. 14(4). e0100723–e0100723. 8 indexed citations
6.
Sun, Tony, et al.. (2023). Identification of ADAR1 p150 and p110 Associated Edit Sites. Methods in molecular biology. 2651. 285–294. 2 indexed citations
7.
Nilsson-Payant, Benjamin E., Skyler Uhl, Adrien Grimont, et al.. (2021). The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication. Journal of Virology. 95(23). e0125721–e0125721. 61 indexed citations
8.
Patel, Roosheel S., Joy E. Tomlinson, Thomas J. Divers, Gerlinde R. Van de Walle, & Brad R. Rosenberg. (2021). Single-cell resolution landscape of equine peripheral blood mononuclear cells reveals diverse cell types including T-bet+ B cells. BMC Biology. 19(1). 13–13. 29 indexed citations
9.
Daniloski, Zharko, Tristan X. Jordan, Hans‐Hermann Wessels, et al.. (2020). Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells. Cell. 184(1). 92–105.e16. 348 indexed citations
11.
Tomlinson, Joy E., Ulrik Fahnøe, Himanshu Sharma, et al.. (2020). Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis. PLoS Pathogens. 16(7). e1008677–e1008677. 16 indexed citations
12.
Clijsters, Linda, Claire Hoencamp, Jorg J. A. Calis, et al.. (2019). Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2Fs. Molecular Cell. 74(6). 1264–1277.e7. 76 indexed citations
13.
Saha, Debjani, Maren de Vries, Aaron Briley, et al.. (2019). The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response. PLoS Pathogens. 15(11). e1007634–e1007634. 35 indexed citations
14.
Rosenberg, Brad R., Catherine A. Freije, Denis Gaucher, et al.. (2018). Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance. PLoS Pathogens. 14(9). e1007290–e1007290. 32 indexed citations
15.
Wu, Xianfang, Viet Loan Dao Thi, Yu-Min Huang, et al.. (2017). Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 172(3). 423–438.e25. 248 indexed citations breakdown →
16.
Honeyman, Joshua N., Elana P. Simon, Nicolas Robine, et al.. (2014). Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma. Science. 343(6174). 1010–1014. 327 indexed citations
17.
Rosenberg, Brad R., Claire Hamilton, Michael Mwangi, Scott Dewell, & F. Nina Papavasiliou. (2011). Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3′ UTRs. Nature Structural & Molecular Biology. 18(2). 230–236. 188 indexed citations
18.
Rosenberg, Brad R., Scott Dewell, & F. Nina Papavasiliou. (2011). Identifying mRNA Editing Deaminase Targets by RNA-Seq. Methods in molecular biology. 718. 103–119. 7 indexed citations
19.
Hamilton, Claire, F. Nina Papavasiliou, & Brad R. Rosenberg. (2010). Diverse functions for DNA and RNA editing in the immune system. RNA Biology. 7(2). 220–228. 42 indexed citations
20.
Rosenberg, Brad R. & F. Nina Papavasiliou. (2007). Beyond SHM and CSR: AID and Related Cytidine Deaminases in the Host Response to Viral Infection. Advances in immunology. 94. 215–244. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026